n-chlorotaurine has been researched along with Chronic Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grapsa, E; Kyriakopoulos, AM; Marcinkiewicz, J; Nagl, M | 1 |
Cha, YN; Kim, C | 1 |
Gottardi, W; Höpfl, R; Nagl, M; Nguyen, VA; Ulmer, H | 1 |
Appenroth, E; Fischer, H; Gotwald, TF; Gschwendtner, A; Gstöttner, M; Kozlov, V; Lass-Flörl, C; Mayr, A; Nagl, M; Neher, A; Ulmer, H | 1 |
1 review(s) available for n-chlorotaurine and Chronic Disease
Article | Year |
---|---|
Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects.
Topics: Animals; Antioxidants; Apoptosis; Chronic Disease; Cytoprotection; Humans; Inflammation; Inflammation Mediators; Macrophage Activation; Macrophages; Neutrophil Activation; Neutrophils; Oxidoreductases; Taurine | 2014 |
2 trial(s) available for n-chlorotaurine and Chronic Disease
Article | Year |
---|---|
Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Chloramines; Chronic Disease; Dermatologic Agents; Double-Blind Method; Drug Evaluation; Female; Humans; Leg Ulcer; Male; Middle Aged; Pain; Taurine; Tosyl Compounds; Treatment Outcome; Wound Healing | 2003 |
Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter.
Topics: Adult; Anti-Infective Agents; Catheterization; Chronic Disease; Female; Humans; Male; Middle Aged; Sinusitis; Spectrophotometry; Taurine; Therapeutic Irrigation | 2005 |
1 other study(ies) available for n-chlorotaurine and Chronic Disease
Article | Year |
---|---|
Swift Cure of a Chronic Wound Infected With Multiresistant
Topics: Administration, Topical; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Chronic Disease; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Lower Extremity; Prognosis; Risk Assessment; Staphylococcal Infections; Taurine; Wound Healing; Wound Infection | 2019 |